Search
for
Sort by
Research 151–180 of 1000+
- Alopecia Areata: Current Treatments and New Directions
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
- JAK inhibitors and alopecia areata
- Comorbidities in patients with alopecia areata
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Coudability hairs: a revisited sign of alopecia areata assessed by trichoscopy
- Topical minoxidil in alopecia areata
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Frontiers in alopecia areata pathobiology research
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata
- Benefit and risk profile of tofacitinib for the treatment of alopecia areata: a systemic review and meta‐analysis
- Endogenous Retinoids in the Pathogenesis of Alopecia Areata
- Vitamin D Concentrations are Decreased in Patients with Alopecia Areata
- Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesicles.
- Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy
- Topical Minoxidil Dose-Response Effect in Alopecia Areata
- Decreased lymphocyte reactivity and auto-immunity in alopecia areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Alopecia areata after dupilumab for atopic dermatitis
- Alopecia areata-successful outcome with microneedling and triamcinolone acetonide
- Histologic features of alopecia areata other than peribulbar lymphocytic infiltrates
- Etiopathogenesis of alopecia areata: Why do our patients get it?
- Evaluation of serum zinc level in patients with newly diagnosed and resistant alopecia areata
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Inhibiting Janus kinases to treat alopecia areata